Journals / Turkish Journal of Endocrinology and Metabolism / 2019 / Cilt: 23 - Sayı: 4

Evaluation of Paraoxonase1 Polymorphisms in Hypothyroid Patients and Their Relationship with Paraoxonase Activity and Serum Lipids

Hipotiroidili Hastalarda Paraoksonaz1 Polimorfizmlerinin Değerlendirilmesi ve Bu Polimorfizmlerin Paraoksonaz Aktivitesi ve Serum Lipidleri ile İlişkisi

Pages
213–221
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: The activity of PON1 declined in the recruited patients compared to that in the control group (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The risk for atherosclerosis increases in hypothyroidism, although its associated mode of pathogenesis has not been determined yet.
📊
Key Findings & Data:Paraoxonase1 (PON1) is an enzyme that is antioxidative and antiatherogenic.
💡
Conclusion & Impact:Results: The activity of PON1 declined in the recruited patients compared to that in the control group (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The risk for atherosclerosis increases in hypothyroidism, although its associated mode of pathogenesis has not been determined yet. Paraoxonase1 (PON1) is an enzyme that is antioxidative and antiatherogenic. This study was planned to determine distributions of PON1 192 and 55 gene polymorphisms in hypothyroid patients and healthy individuals and to investigate the effects of these polymorphisms on PON1 activity and serum lipids. Material and Methods: Seventy-five primary hypothyroid patients and 45 healthy volunteers were recruited into the study and PON1 192 and 55 gene polymorphisms, serum PON1 activity, and lipid profiles were measured in them. Results: The activity of PON1 declined in the recruited patients compared to that in the control group (p

Özet

Amaç: Hipotiroidizmde ateroskleroz riskinin arttığı bilinmesine rağmen, hipotiroidizmdeki aterosklerozun patogenezi henüz tam olarak açıklanamamıştır. Paraoksonaz1 (PON1), antioksidan ve antiaterojenik etkileri olduğu bilinen bir enzimdir. Bu çalışma, hipotiroidili hastalarda ve sağlıklı bireylerde PON1 192 ve 55 gen polimorfizmlerinin dağılımını belirlemek ve bu polimorfizmlerin PON1 aktivitesi ve serum lipidleri üzerine etkilerini araştırmak için planlandı. Gereç ve Yöntemler: Çalışmaya 75 primer hipotiroidi hastası ve 45 sağlıklı gönüllü dâhil edildi. PON1 192 ve 55 gen polimorfizmleri, serum PON1 aktivitesi ve lipid profilleri ölçüldü. Bulgular: Hastalarda PON1 aktivitesi kontrol grubuna göre düşüktü (p

🔖

Cite This Article

BAYRAM, F., MERT, M., ELMALI, F., BAŞKOL, G., ÇAKIR, İ., CANİKLİOĞLU, A., ÖZKUL, Y., GÜNAY, N. E. (2022). Evaluation of Paraoxonase1 Polymorphisms in Hypothyroid Patients and Their Relationship with Paraoxonase Activity and Serum Lipids. Turkish Journal of Endocrinology and Metabolism, Cilt: 23 - Sayı: 4, 213–221. https://ajindex.com/articles/605424

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Friedman TC. Thyroid gland. In: Andreoli TE, Carpenter C, Griggs RC, Benjamin IJ, Wing EJ, Fitz G, eds. Cecil Essentials of Medicine (9th ed). Philadelphia: Elsevier Saunders; 2016;633- 641
  2. Tutal E, Özbek M, Arslan MS, Karakose M, Gungunes A, Demirci T, Çalışkan M, Ünsal İÖ, Topaloglu O, Öztürk G, Çakal E. Serum heart-type fatty acidbinding protein levels in patients with overt hypothyroidism. Turk J Endocrinol Metab. 2017;21:15-18. [Crossref] 3. Ichiki T. Thyroid hormone and vascular remodeling. J Atheroscler Thromb. 2016;23:266-275. [Crossref] [PubMed] 4. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation. 2002;106:3143-3421. [Crossref] [PubMed] 5. Eren MA, Tabur S, Torun AN, Torun AN, Ulaş T, Dağ ÖF, Aksoy N, Sabuncu T. Antioxidant status and serum prolidase activity in women with subclinical hypothroidism. Turk J Endocrinol Metab. 2015;19:38-41. [Crossref] 6. Deakin SP, James RW. Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1. Clin Sci (Lond). 2004;107:435-447. [Crossref] [PubMed] 7. Précourt LP, Amre D, Denis MC, Lavoie JC, Delvin E, Seidman E, Levy E. The three-gene paraoxonase family: physiologic roles, actions and regulation. Atherosclerosis. 2011;214:20-36. [Crossref] [PubMed] 8. Mohamed RH, Mohamed RH, Karam RA, Abd El-Aziz TA. The relationship between paraoxonase1-192 polymorphism and activity with coronary artery disease. Clin Biochem. 2010;43:553-558. [Crossref] [PubMed] 9. Sarandöl E, Taş S, Dirican M, Serdar Z. Oxidative stress and serum paraoxonase activity in experimental hypothyroidism: effect of vitamin E supplementation. Cell Biochem Funct. 2005;23:1-8. [Crossref] [PubMed] 10.Baskol G, Atmaca H, Tanrıverdi F, Baskol M, Kocer D, Bayram F. Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism before and after treatment. Exp Clin Endocrinol Diabetes. 2007;115:522-526. [Crossref] [PubMed] 11.Cebeci E, Oner FA, Usta M, Yurdakul S, Erguney M. Evaluation of oxidative stress, the activities of paraoxonase and arylesterase in patient with subclinical hypothyroidism. J Investig Med. 2012;60:23-28. [Crossref] [PubMed] 12.Ates I, Altay M, Yilmaz FM, Topcuoglu C, Yilmaz N, Berker D, Guler S. The impact of levothyroxine sodium treatment on oxidative stress in Hashimoto’s thyroiditis. Eur